Liu; Yijia

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liu; Yijia.The latest application filed is for "composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases".

Company Profile

0.6.13

Liu; Yijia - Gaithersburg MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition And Methods Of Rnai Therapeutics For Treatment Of Cancer And Other Neovascularization Diseases App 20110124710 - Liu; Yijia ; et al.	2011-05-26
COMPOSITIONS COMPRISING HUMAN EGFR-siRNA AND METHODS OF USE App 20110046067 - Yang; Xiaodong ; et al.	2011-02-24
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases Grant 7,893,244 - Liu , et al. February 22, 2	2011-02-22
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases Grant 7,893,243 - Liu , et al. February 22, 2	2011-02-22
Inhibitory Polynucleotide Compositions And Methods For Treating Cancer App 20110038849 - Xie; Frank Y. ; et al.	2011-02-17
Methods And Compositions For Treatment Of Cancer And Other Angiogenesis-related Diseases App 20110015249 - Xie; Frank Y. ; et al.	2011-01-20
Composition and method of RNAi therapeutics for treatment of cancer and other neovascularization diseases Grant 7,786,092 - Liu , et al. August 31, 2	2010-08-31
Targets for tumor growth inhibition Grant 7,781,414 - Lu , et al. August 24, 2	2010-08-24
THERAPEUTIC siRNA MOLECULES FOR REDUCING VEGFR1 EXPRESSION IN VITRO AND IN VIVO App 20100210710 - Xie; Frank Y. ; et al.	2010-08-19
Targets For Tumor Growth Inhibition App 20100203036 - LU; PATRICK Y. ; et al.	2010-08-12
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases Grant 7,723,316 - Liu , et al. May 25, 2	2010-05-25
Compositions and Methods of Using siRNA to Knockdown Gene Expression and to Improve Solid Organ and Cell Transplantation App 20100028848 - Parker; Marie Denise ; et al.	2010-02-04
COMPOSITION AND METHODS OF RNAi THERAPEUTICS FOR TREATMENT OF CANCER AND OTHER NEOVASCULARIZATION DISEASES App 20090227657 - Liu; Yijia ; et al.	2009-09-10
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases App 20090203894 - Liu; Yijia ; et al.	2009-08-13
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases Grant 7,534,878 - Liu , et al. May 19, 2	2009-05-19
Composition and methods of RNAI therapeutics for treatment of cancer and other neovascularization diseases App 20090118208 - Liu; Yijia ; et al.	2009-05-07
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases App 20080241198 - Liu; Yijia ; et al.	2008-10-02
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases App 20080220027 - Liu; Yijia ; et al.	2008-09-11
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases App 20080153771 - Liu; Yijia ; et al.	2008-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.